Stocks · News reference

DarioHealth Expects DarioIQ AI Platform Deployments To Increase Annual Business-To-Consumer Recurring Revenue By 10%-15%

Jul 13, 2026, 11:35 AMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARSep 4, 2026, 8:05 PMSEC EDGAR
8-K filing — DarioHealth Corp. (DRIO)
Filed: 2026-09-04 AccNo: 0001104659-26-105495 Size: 186 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
DRIO
BenzingaAug 19, 2026, 3:45 PMBenzinga Newsdesk
Alliance Global Partners Initiates Coverage On DarioHealth with Buy Rating, Announces Price Target of $12
Alliance Global Partners analyst Scott Henry initiates coverage on DarioHealth (NASDAQ:DRIO) with a Buy rating and announces Price Target of $12.
DRIO
BenzingaAug 12, 2026, 3:17 PMBenzinga Newsdesk
TD Cowen Maintains Hold on DarioHealth, Lowers Price Target to $8
TD Cowen analyst Charles Rhyee maintains DarioHealth (NASDAQ:DRIO) with a Hold and lowers the price target from $11 to $8.
DRIO
BenzingaAug 11, 2026, 10:33 AMBenzinga Newsdesk
DarioHealth Q2 Adj. EPS $(0.72) Beats $(1.22) Estimate, Sales $5.177M Miss $5.923M Estimate
DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(1.22) by 40.98 percent. This is a 82.44 percent increase over losses of $(4.10) per share from the
DRIO